{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,11]],"date-time":"2024-08-11T21:51:48Z","timestamp":1723413108073},"reference-count":57,"publisher":"Elsevier BV","issue":"30","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1016\/j.vaccine.2007.02.041","type":"journal-article","created":{"date-parts":[[2007,3,8]],"date-time":"2007-03-08T12:02:17Z","timestamp":1173355337000},"page":"5631-5636","source":"Crossref","is-referenced-by-count":20,"title":["Understanding the natural variability of prion diseases"],"prefix":"10.1016","volume":"25","author":[{"given":"Markus","family":"Geissen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Krasemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakob","family":"Matschke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Glatzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9402","key":"10.1016\/j.vaccine.2007.02.041_bib1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0140-6736(03)15171-9","article-title":"Transmissible spongiform encephalopathies","volume":"363","author":"Collins","year":"2004","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.vaccine.2007.02.041_bib2","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1212\/01.WNL.0000160117.56690.B2","article-title":"Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada","volume":"64","author":"Ladogana","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.vaccine.2007.02.041_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.vetmic.2006.06.016","article-title":"Atypical BSE in Germany-Proof of transmissibility and biochemical characterization","author":"Buschmann","year":"2006","journal-title":"Vet Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2007.02.041_bib4","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/(SICI)1096-8628(19991203)87:4<311::AID-AJMG6>3.0.CO;2-5","article-title":"Novel twelve-generation kindred of fatal familial insomnia from germany representing the entire spectrum of disease expression","volume":"87","author":"Harder","year":"1999","journal-title":"Am J Med Genet"},{"issue":"9006","key":"10.1016\/j.vaccine.2007.02.041_bib5","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0140-6736(96)91412-9","article-title":"A new variant of Creutzfeldt-Jakob disease in the UK","volume":"347","author":"Will","year":"1996","journal-title":"Lancet"},{"issue":"6650","key":"10.1016\/j.vaccine.2007.02.041_bib6","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/38925","article-title":"The same prion strain causes vCJD and BSE [letter]","volume":"389","author":"Hill","year":"1997","journal-title":"Nature"},{"issue":"6650","key":"10.1016\/j.vaccine.2007.02.041_bib7","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/39057","article-title":"Transmissions to mice indicate that \u2018new variant\u2019 CJD is caused by the BSE agent","volume":"389","author":"Bruce","year":"1997","journal-title":"Nature"},{"issue":"6602","key":"10.1016\/j.vaccine.2007.02.041_bib8","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/383666a0","article-title":"Spongiform encephalopathies: a suspicious signature","volume":"383","author":"Aguzzi","year":"1996","journal-title":"Nature"},{"issue":"6585","key":"10.1016\/j.vaccine.2007.02.041_bib9","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/381734a0","article-title":"Between cows and monkeys","volume":"381","author":"Aguzzi","year":"1996","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.vaccine.2007.02.041_bib10","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1212\/WNL.55.8.1075","article-title":"Iatrogenic Creutzfeldt-Jakob disease at the millennium","volume":"55","author":"Brown","year":"2000","journal-title":"Neurology"},{"issue":"7113","key":"10.1016\/j.vaccine.2007.02.041_bib11","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nature05294","article-title":"Prions and their partners in crime","volume":"443","author":"Caughey","year":"2006","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.vaccine.2007.02.041_bib12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/ana.410050212","article-title":"Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering","volume":"5","author":"Masters","year":"1979","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.vaccine.2007.02.041_bib13","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1212\/WNL.55.6.811","article-title":"Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease","volume":"55","author":"Zerr","year":"2000","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.vaccine.2007.02.041_bib14","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0304-3940(97)00215-2","article-title":"Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease","volume":"225","author":"Otto","year":"1997","journal-title":"Neurosci Lett"},{"issue":"4","key":"10.1016\/j.vaccine.2007.02.041_bib15","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1212\/01.wnl.0000230159.67128.00","article-title":"CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease","volume":"67","author":"Sanchez-Juan","year":"2006","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.vaccine.2007.02.041_bib16","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s002340100695","article-title":"Sequential MRI in a case of Creutzfeldt-Jakob disease","volume":"44","author":"Tribl","year":"2002","journal-title":"Neuroradiology"},{"issue":"8","key":"10.1016\/j.vaccine.2007.02.041_bib17","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1109\/TMI.2006.876133","article-title":"Differentiation of sCJD and vCJD forms by automated analysis of basal ganglia intensity distribution in multisequence MRI of the brain-definition and evaluation of new MRI-based ratios","volume":"25","author":"Linguraru","year":"2006","journal-title":"IEEE Trans Med Imaging"},{"issue":"3","key":"10.1016\/j.vaccine.2007.02.041_bib18","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s00415-005-0648-8","article-title":"Sporadic Creutzfeldt-Jakob disease A comparison of pathological findings and diffusion weighted imaging","volume":"252","author":"Russmann","year":"2005","journal-title":"J Neurol"},{"issue":"3","key":"10.1016\/j.vaccine.2007.02.041_bib19","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s004390050204","article-title":"Genetic basis of Creutzfeldt-Jakob disease in the United Kingdom\u2014a systematic analysis of predisposing mutations and allelic variation in the PRNP gene","volume":"98","author":"Windl","year":"1996","journal-title":"Hum Genet"},{"issue":"4","key":"10.1016\/j.vaccine.2007.02.041_bib20","first-page":"828","article-title":"Mutation and polymorphism of the prion protein gene in Libyan Jews with Creutzfeldt-Jakob disease (CJD)","volume":"53","author":"Gabizon","year":"1993","journal-title":"Am J Hum Genet"},{"issue":"8715","key":"10.1016\/j.vaccine.2007.02.041_bib21","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/0140-6736(90)93443-S","article-title":"Mutation in codon 200 of scrapie amyloid precursor gene linked to Creutzfeldt-Jakob disease in Sephardic Jews of Libyan and non-Libyan origin [letter]","volume":"336","author":"Goldfarb","year":"1990","journal-title":"Lancet"},{"issue":"8713","key":"10.1016\/j.vaccine.2007.02.041_bib22","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/0140-6736(90)92073-Q","article-title":"Mutation in codon 200 of scrapie amyloid protein gene in two clusters of Creutzfeldt-Jakob disease in Slovakia [letter]","volume":"336","author":"Goldfarb","year":"1990","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2007.02.041_bib23","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s00439-005-0020-1","article-title":"Genetic prion disease: the EUROCJD experience","volume":"118","author":"Kovacs","year":"2005","journal-title":"Hum Genet"},{"issue":"Pt. 3","key":"10.1016\/j.vaccine.2007.02.041_bib24","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/brain\/115.3.687","article-title":"Inherited prion disease with 144 base pair gene insertion. 2. Clinical and pathological features","volume":"115","author":"Collinge","year":"1992","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.vaccine.2007.02.041_bib25","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1006\/bbrc.1993.1447","article-title":"An amber mutation of prion protein in Gerstmann\u2013Straussler syndrome with mutant PrP plaques","volume":"192","author":"Kitamoto","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"issue":"6213","key":"10.1016\/j.vaccine.2007.02.041_bib26","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/338342a0","article-title":"Linkage of a prion protein missense variant to Gerstmann\u2013Straussler syndrome","volume":"338","author":"Hsiao","year":"1989","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.vaccine.2007.02.041_bib27","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0022-510X(94)90138-4","article-title":"A variant of Gerstmann\u2013Straussler\u2013Scheinker disease carrying codon 105 mutation with codon 129 polymorphism of the prion protein gene: a clinicopathological study","volume":"127","author":"Itoh","year":"1994","journal-title":"J Neurol Sci"},{"issue":"1","key":"10.1016\/j.vaccine.2007.02.041_bib28","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1750-3639.1995.tb00578.x","article-title":"Gerstmann\u2013Straussler\u2013Scheinker disease and the Indiana kindred","volume":"5","author":"Ghetti","year":"1995","journal-title":"Brain Pathol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.02.041_bib29","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/ng0492-68","article-title":"Mutant prion proteins in Gerstmann\u2013Straussler\u2013Scheinker disease with neurofibrillary tangles","volume":"1","author":"Hsiao","year":"1992","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.vaccine.2007.02.041_bib30","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1750-3639.1995.tb00576.x","article-title":"Fatal familial insomnia and familial Creutzfeldt-Jakob disease: clinical, pathological and molecular features","volume":"5","author":"Gambetti","year":"1995","journal-title":"Brain Pathol"},{"issue":"5083","key":"10.1016\/j.vaccine.2007.02.041_bib31","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1126\/science.1439789","article-title":"Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism","volume":"258","author":"Goldfarb","year":"1992","journal-title":"Science"},{"issue":"9165","key":"10.1016\/j.vaccine.2007.02.041_bib32","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/S0140-6736(99)01342-2","article-title":"Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease [letter]","volume":"353","author":"Alperovitch","year":"1999","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.vaccine.2007.02.041_bib33","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1056\/NEJMoa030351","article-title":"Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease","volume":"349","author":"Glatzel","year":"2003","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.vaccine.2007.02.041_bib34","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(05)70225-8","article-title":"Coexistence of multiple PrPSc types in individuals with Creutzfeldt-Jakob disease","volume":"4","author":"Polymenidou","year":"2005","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.vaccine.2007.02.041_bib35","doi-asserted-by":"crossref","first-page":"927","DOI":"10.2353\/ajpath.2006.050788","article-title":"Detection and localization of PrPSc in the skeletal muscle of patients with variant, iatrogenic, and sporadic forms of Creutzfeldt-Jakob disease","volume":"168","author":"Peden","year":"2006","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.02.041_bib36","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1073\/pnas.97.1.145","article-title":"NMR solution structure of the human prion protein","volume":"97","author":"Zahn","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"issue":"19\u201320","key":"10.1016\/j.vaccine.2007.02.041_bib37","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1007\/s00018-006-6140-5","article-title":"The intriguing prion disorders","volume":"63","author":"Abid","year":"2006","journal-title":"Cell Mol Life Sci"},{"issue":"6","key":"10.1016\/j.vaccine.2007.02.041_bib38","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1365-2990.2005.00697.x","article-title":"Phenotypic variability in human prion diseases","volume":"31","author":"Ironside","year":"2005","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.vaccine.2007.02.041_bib39","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.90.23.10962","article-title":"Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins","author":"Pan","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.vaccine.2007.02.041_bib40","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1371\/journal.pmed.0030014","article-title":"Analysis of prion strains by PrP(Sc) profiling in sporadic Creutzfeldt-Jakob disease","volume":"3","author":"Schoch","year":"2005","journal-title":"PLoS Med"},{"issue":"3","key":"10.1016\/j.vaccine.2007.02.041_bib41","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1371\/journal.ppat.0020026","article-title":"The expanding universe of prion diseases","volume":"2","author":"Watts","year":"2006","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2007.02.041_bib42","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M313220200","article-title":"Effects of different experimental conditions on the PrPSc core generated by protease digestion: Implications for strain typing and molecular classification of CJD","author":"Notari","year":"2004","journal-title":"J Biol Chem"},{"issue":"Pt. 6","key":"10.1016\/j.vaccine.2007.02.041_bib43","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1093\/brain\/awg125","article-title":"Molecular classification of sporadic Creutzfeldt-Jakob disease","volume":"126","author":"Hill","year":"2003","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.vaccine.2007.02.041_bib44","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W","article-title":"Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects","volume":"46","author":"Parchi","year":"1999","journal-title":"Ann Neurol"},{"issue":"Pt. 9","key":"10.1016\/j.vaccine.2007.02.041_bib45","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1093\/brain\/awl224","article-title":"Classification of sporadic Creutzfeldt-Jakob disease revisited","volume":"129","author":"Cali","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.vaccine.2007.02.041_bib46","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0140-6736(01)05403-4","article-title":"Tissue distribution of protease resistant prion protein in variant CJD using a highly sensitive immuno-blotting assay","volume":"358","author":"Wadsworth","year":"2001","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.vaccine.2007.02.041_bib47","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1073\/pnas.0409651102","article-title":"Diagnosis of human prion disease","volume":"102","author":"Safar","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Pt. 10","key":"10.1016\/j.vaccine.2007.02.041_bib48","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1099\/vir.0.81935-0","article-title":"Application of an immunocapillary electrophoresis assay to the detection of abnormal prion protein in brain, spleen and blood specimens from patients with variant Creutzfeldt-Jakob disease","volume":"87","author":"Lourenco","year":"2006","journal-title":"J Gen Virol"},{"issue":"10","key":"10.1016\/j.vaccine.2007.02.041_bib49","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/2654","article-title":"Eight prion strains have PrP(Sc) molecules with different conformations","volume":"4","author":"Safar","year":"1998","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.vaccine.2007.02.041_bib50","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.cell.2005.02.011","article-title":"In vitro generation of infectious scrapie prions","volume":"121","author":"Castilla","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2007.02.041_bib51","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0076-6879(06)12001-7","article-title":"Protein misfolding cyclic amplification for diagnosis and prion propagation studies","volume":"412","author":"Castilla","year":"2006","journal-title":"Meth Enzymol"},{"issue":"5783","key":"10.1016\/j.vaccine.2007.02.041_bib52","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1126\/science.1129051","article-title":"Presymptomatic detection of prions in blood","volume":"313","author":"Saa","year":"2006","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.vaccine.2007.02.041_bib53","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1750-3639.1995.tb00625.x","article-title":"Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases)","volume":"5","author":"Budka","year":"1995","journal-title":"Brain Pathol"},{"key":"10.1016\/j.vaccine.2007.02.041_bib54","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/bmb\/66.1.121","article-title":"Neuropathology of prion diseases","volume":"66","author":"Budka","year":"2003","journal-title":"Br Med Bull"},{"issue":"5684","key":"10.1016\/j.vaccine.2007.02.041_bib55","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1126\/science.1100195","article-title":"Synthetic mammalian prions","volume":"305","author":"Legname","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2007.02.041_bib56","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/bmb\/66.1.141","article-title":"Immune system and peripheral nerves in propagation of prions to CNS","volume":"66","author":"Aguzzi","year":"2003","journal-title":"Br Med Bull"},{"issue":"4","key":"10.1016\/j.vaccine.2007.02.041_bib57","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/archneur.62.4.545","article-title":"Human prion diseases: molecular and clinical aspects","volume":"62","author":"Glatzel","year":"2005","journal-title":"Arch Neurol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07002198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07002198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T23:20:46Z","timestamp":1546989646000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07002198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":57,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S0264410X07002198"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.02.041","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]}}}